Search results with tag "Cytochromes p450"
Interactions médicamenteuses, cytochromes P450 et P ...
www.hug.chInteractions médicamenteuses, cytochromes P450 et P-glycoprotéine (Pgp) 1A2 2B6 2C8 2C92C19 2D6 2E1 3A4/5 Pgp1A2 2C19 2D6 3A4/5 1A2 2B6 2C8 2C9 2C19 2D6 2E1 3A4/5 Pgp Substrats des cytochromes P450 et de la Pgp Majeure Mineure ! Métabolite actif acénocoumarol acide méfénamique acide valproïque! agomelatine alfentanil alprazolam amiodarone!
Singulair (Montelukast Sodium)
www.accessdata.fda.govcytochromes P450 3A4 (e.g., ketoconazole, erythromycin) or 2C9 (e.g., fluconazole) on montelukast pharmacokinetics have not been conducted. Based on further. in vitro. results in human liver microsomes, therapeutic plasma concentrations of montelukast do not inhibit cytochromes P450 3A4, 2C9, 1A2, 2A6, 2C19, or 2D6 (see . Drug Interactions). In ...
COURS DE PHARMACOCINÉTIQUE
www.recherchecliniquepariscentre.frRéactions de phase I : réactions d’oxydation par les cytochromes P450 (CYP3A4 (50%), 2D6 (15%) et 2C) Réactions de phase II: réactions de conjugaison glucurono, sulfo, glutathion, N-acétyltransferase. • Transporteurs : pompes d’efflux exprimées au niveau de l’intestin, du foie, BHE s’opposent à l’absorption intestinale
NONCLINICAL SAFETY TESTING IN SUPPORT OF …
database.ich.orgCYP Cytochromes P450 . DRF Dose Range-Finding . ePPND Enhanced Pre- and Postnatal Development . FIH First in Human . FOB Functional Observational Battery . GABA Gamma Aminobutyric Acid . GFR Glomerular Filtration Rate . GI Gastrointestinal . HPG Human Pituitary Gonadotropin . ICH International Council for Harmonisation . JAS Juvenile Animal Study
Cytochromes P450 - Purdue University
www.purdue.eduCytochromes P450 3 PHRM 836, Biochem II September 2014 ! Catalysis: monooxygenase. ! Catalyze Insertion of one atom of molecular oxygen ! Drug interactions of cytochrome P450s ! Major role in drug detoxification ! type CYP3A4 estimated to act on ~ 50% of known drugs ! e.g. the antibiotic erythromycin ...